Copy
If this email does not display correctly, click here
Newsletter #137
October 11th, 2018
YouTube LinkedIn Google+ Twitter
GMFH
Editorial

Dear Friends,

Our newsletter begins with a review, which catalogs the pre-clinical and clinical evidence currently available for using probiotics to improve various disease states. The conditions under focus include obesity and diabetes, necrotizing enterocolitis, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).

Next comes an article about the transmission of the microbiome from mother to infant during the first months of life. Then comes a study that explores how fecal microbiota transplantation may change gut microbiota composition while a placebo improves symptoms in IBS patients. And finally, we discuss an article showing how compositional changes in intestinal phage communities occur during colitis in mice.

The GMFH publishing team

A review explores the influence of probiotics on intestinal barrier integrity in various disease states
GMFH
Two studies characterize the transmission of the microbiome from mother to infant during the first months of life

Two studies characterize the transmission of the microbiome from mother to infant during the first months of life


Gut microbial colonization during early life influences human physiology, including the maturation of the immune system, nutrient absorption and...


Share: Facebook Twitter Google+ Linkedin Email  
Fecal microbiota transplantation may change gut microbiota composition but placebo improves symptoms in IBS patients

Fecal microbiota transplantation may change gut microbiota composition but placebo improves symptoms in IBS patients


Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although...


Share: Facebook Twitter Google+ Linkedin Email  
A mouse model of colitis shows the relevance of phages on intestinal inflammation

A mouse model of colitis shows the relevance of phages on intestinal inflammation


An imbalance in gut microbial communities has been associated with inflammatory bowel diseases (IBD) and research aimed at elucidating the contribution of the microbiota to inflammatory diseases has primarily focused on...


Share: Facebook Twitter Google+ Linkedin Email  
©2018 Gut Microbiota For Health
If you need further information send us an email to contact@gutmicrobiotaforhealth.com

You have received this e-mail because you have shown an interest in receiving news from us. If you don’t want to continue receiving information from us, please unsubscribe

www.gutmicrobiotaforhealth.com is edited by
ESNM
 
Unsubscribe from this list Update subscription preferences
Before print this message, please check that it is really necessary